Molecular Partners AG (MOLN) — Cash Flow-to-Debt Ratio
Molecular Partners AG (MOLN) has a Cash Flow-to-Debt Ratio of -0.57x as of September 2025, meaning its operating cash flow of CHF-9.49 Million could theoretically repay -1% of its total liabilities (CHF16.62 Million) in one year. See MOLN financial flexibility score to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Molecular Partners AG Cash Flow-to-Debt Ratio (2013–2024)
Historical debt coverage capacity for Molecular Partners AG across 12 annual periods. For the full cash flow conversion analysis, see MOLN cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Molecular Partners AG (2013–2024)
Year-by-year debt coverage analysis for Molecular Partners AG. Check MOLN operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CHF) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -3.51x | CHF-59.25 Million | CHF16.89 Million | ▼ -30.3% |
| 2023 | -2.69x | CHF-59.01 Million | CHF21.92 Million | ▼ -161.5% |
| 2022 | 4.38x | CHF118.57 Million | CHF27.09 Million | ▲ +414.6% |
| 2021 | -1.39x | CHF-90.95 Million | CHF65.38 Million | ▼ -285.6% |
| 2020 | -0.36x | CHF-28.98 Million | CHF80.33 Million | ▼ -1441.5% |
| 2019 | -0.02x | CHF-1.19 Million | CHF50.80 Million | ▲ +96.5% |
| 2018 | -0.67x | CHF-42.47 Million | CHF63.45 Million | ▲ +53.7% |
| 2017 | -1.45x | CHF-40.02 Million | CHF27.69 Million | ▼ -97.3% |
| 2016 | -0.73x | CHF-35.38 Million | CHF48.30 Million | ▼ -286.9% |
| 2015 | 0.39x | CHF26.50 Million | CHF67.60 Million | ▲ +257.5% |
| 2014 | -0.25x | CHF-11.33 Million | CHF45.54 Million | ▼ -13.0% |
| 2013 | -0.22x | CHF-13.61 Million | CHF61.80 Million | — |